NCT06448754
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06448754
Title Volrustomig Priming Regimens Exploratory Phase II Platform Study (eVOLVE-01)
Acronym eVOLVE-01
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | ITA | GRC | FRA | ESP | CHE

Facility Status City State Zip Country Details
Research Site Los Angeles California 90067 United States Details
Research Site Chapel Hill North Carolina 27514 United States Details
Research Site Beijing 100730 China Details
Research Site Hangzhou 310014 China Details
Research Site Jinan 250013 China Details
Research Site Yantai 264000 China Details
Research Site Zhengzhou 450000 China Details
Research Site Bois-Guillaume 76031 France Details
Research Site Caen 14076 France Details
Research Site Dijon 21079 France Details
Research Site Montpellier 34070 France Details
Research Site Batumi 6010 Georgia Details
Research Site Tbilisi '0159 Georgia Details
Research Site Tbilisi 0112 Georgia Details
Research Site Tbilisi 0114 Georgia Details
Research Site Tbilisi 0144 Georgia Details
Research Site Tbilisi 186 Georgia Details
Research Site Athens 115 27 Greece Details
Research Site Athens 12462 Greece Details
Research Site Elaiones 546 23 Greece Details
Research Site Piraeus 185 47 Greece Details
Research Site Thessaloniki 57001 Greece Details
Research Site Genoa 16132 Italy Details
Research Site Meldola 47014 Italy Details
Research Site Milan 20133 Italy Details
Research Site Naples 80131 Italy Details
Research Site Orbassano 10043 Italy Details
Research Site Perugia 06132 Italy Details
Research Site Rozzano 20089 Italy Details
Research Site Udine 33100 Italy Details
Research Site Verona 37134 Italy Details
Research Site Kuala Lumpur 59100 Malaysia Details
Research Site Kuching 93586 Malaysia Details
Research Site Perai 13700 Malaysia Details
Research Site Lisbon 1169-050 Portugal Details
Research Site Lisbon 1400-038 Portugal Details
Research Site Lisbon 1649-035 Portugal Details
Research Site Porto 4099-001 Portugal Details
Research Site Cluj-Napoca 400641 Romania Details
Research Site Craiova 200542 Romania Details
Research Site Floreşti 407280 Romania Details
Research Site Belgrade 11000 Serbia Details
Research Site Seongnam 13620 South Korea Details
Research Site Seoul 03722 South Korea Details
Research Site Suwon 16247 South Korea Details
Research Site A Coruña 15009 Spain Details
Research Site Alcorcón 28922 Spain Details
Research Site Barcelona 08041 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Málaga 29004 Spain Details
Research Site Pamplona 31008 Spain Details
Research Site Santander 39008 Spain Details
Research Site Santiago de Compostela 15706 Spain Details
Research Site Valencia 46015 Spain Details
Research Site Valencia 46026 Spain Details
Research Site Geneva 1205 Switzerland Details
Research Site Lausanne 1011 Switzerland Details
Research Site Winterthur 8401 Switzerland Details
Research Site Zurich 8091 Switzerland Details
Research Site Changhua 50006 Taiwan Details
Research Site New Taipei City 23561 Taiwan Details
Research Site Taipei 106 Taiwan Details
Research Site Taipei 110 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field